SlideShare a Scribd company logo
Rob Pleticha, Online Communities Manager, EURORDIS
International MG
Community
EURORDIS is a non-governmental patient-
driven alliance of patient organisations
representing 571 rare disease patient
organisations in 52 countries.
RareConnect project
RareConnect.org is an online social network for patients and
families.
Communities are built in partnership with patient groups who
help create, moderate, and maintain.
Each community is in 5 languages with human translation.
There are 54 rare diseases currently listed on RareConnect,
including porphyria.
MG community on RareConnect
Patient-centered community that
promotes global conversation and
connections between patients, families
and caregivers to improve the lives of
people living with rare diseases.
Project Aims
• facilitate patient and carer peer support
• empower patients and carers to trust
their experience
• promote progress in research through
patient generated knowledge
• build relationships by inviting
intervention from medical professionals
MG Community
• Launched June 2013 in 5 languages
– FR, EN, DE, IT, ES
• Seeded with stories, videos, articles…
• Human translation of all future stories
automatically
• On demand human translation and Google
Translator for forum posts
MG Community
• Many topics set for discussion, few responses.
• 145 registered members who have written 7
testimonials.
• 3 articles and 31 forum topics.
Let’s go over some statistics from the MG
community…
Partners and Patient groups involved
The MG community in numbers
5,608 total unique visitors (since June 19th)
Where do the members come from?
1. Unknown 38
2. Italy 27
3. United States 16
4. United Kingsom 9
5. Spain 9
6. Romania 8
7. France 9
8. Ireland 3
9. Martinique 2
10. Switzerland 2
11. Perú 2
12. Hungary 1
13. Netherlands 1
Total of Members: 145
Where do visitors come from?
1. Italy 1,112
2. United States 916
3. France 692
4. Germany 325
5. Spain 316
6. United Kingdom 316
7. Mexico 297
9. Romania 202
10. Canada 126
11. Belgium 118
12. Hungary 106
13. Peru 81
Total of countries: 89
Total of visitors: 5,608
How do visitors find the community?
–Google  3,046
–Direct traffic  812
–Facebook  806
–Mobile Facebook  375
–Eurordis.org 118
–Miastenie.ro 90
–Twitter 73
Which search terms are used?
– myasthenia gravis
– miastenia gravis
– myasthenia gravis association
– myasthénie forum
– myasthenie medicaments interdits
– miastenia
– alimentazione miastenia gravis
– liste medicaments interdit myasthenie
– miastenia gravis forum
– myasthenia gravis uk
- myasthenia gravis video
- myasthénie grave
- sport e miastenia
- www.mga-charity.org
- accociation de myasthénie grav
Which topics are being discussed?
Why the MG community on
RareConnect?
• Patient data is not sold
• Patient groups govern the community and drive where
the project goes
• Human translation of stories and forum posts across 5
languages on key issues like accessing treatments
• Help us create an international space for supporting
patients and their families
Privacy on RareConnect
• You can decide if you want a public or private profile.
• Check a box and your message will only be viewable for
registered members.
• Use a nickname.
• The RareConnect team keeps an eye on all the community
members to ensure they belong there.
If a patient group wants to be involved
on the MG Community
• Join: http://www.rareconnect.org/en/register
• Encourage your members to join the international conversation
enabled by human translation
• Share the link to the Community on your website, social media,
newsletter
• Place badge on your website/blog or add RSS feed to your website
• Post updates on your group’s activities, share an update to your
family’s journey
How can we grow and engage
members?
What new content can be added?
Keeping communities active
• Organise a webinar with a specialist or researcher
• Ask a healthcare professional to write about their
work
• Create a short video interview
• Share photos from your recent event
• Share your story as a patient or a caregiver
Trimethylaminuria (TMAU) Webinars
• 5 webinars with prominent specialists
• Over 140 attendees
• Webinars are recorded
• Researchers answer patient questions after
the presentation
• Patients use webinar as gathering place to
share experience via chat
Involvement of medical experts
Involvement of medical experts
Community poll & Infographic
- Translated into 5 languages
- Designed by patient groups
Community poll & Infographic
- Visual and attractive
- Perfect for Social Media
- Available in 6 languages
(including chinese)
Alkaptonuria (AKU) clinical trials
Video Interviews
Patient organisations activites
RareConnect vs. Facebook
Here are a few differences between RareConnect and Facebook:
- Facebook has advertising and sells your information to marketers.
- RareConnect does not have advertising and does not share information
with ANY 3rd parties.
- RareConnect has human translation across 5 languages.
- Facebook uses machine translation.
-Facebook may delete old posts in Groups, without warning or explanation,
old messages disappear.
- RareConnect keeps all messages and stories in the same place, with
permanent links.
- Facebook isn't that concerned with rare diseases.
- RareConnect staff at EURORDIS and NORD want to assist patient groups in
using RareConnect to build an international diseases movement.
www.facebook.com/rareconnect
robert.pleticha@eurordis.org
marta.campabadal@eurordis.org
+34 663 092 790
@rareconnect
www.youtube.com/user/eurordis
Thanks, let us know how we
can work together
More information:

More Related Content

Similar to Update on the Mysasthenia Gravis community on RareConnect.org

Christel Nourissier Rare Disease Communities Intro
Christel Nourissier Rare Disease Communities IntroChristel Nourissier Rare Disease Communities Intro
Christel Nourissier Rare Disease Communities IntroMihaiela Fazacas
 
Patient entrepeneurs, pop up uni, 9am, 3 september 2015
Patient entrepeneurs, pop up uni, 9am, 3 september 2015Patient entrepeneurs, pop up uni, 9am, 3 september 2015
Patient entrepeneurs, pop up uni, 9am, 3 september 2015
NHS England
 
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
jangeissler
 
The Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacyThe Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacy
jangeissler
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare disease
EURORDIS - Rare Diseases Europe
 
Clinical Social Franchising: Organizing private healthcare providers to addre...
Clinical Social Franchising: Organizing private healthcare providers to addre...Clinical Social Franchising: Organizing private healthcare providers to addre...
Clinical Social Franchising: Organizing private healthcare providers to addre...
The Private Sector in Health Symposium
 
Iadpo membership invitation&information
Iadpo membership invitation&informationIadpo membership invitation&information
Iadpo membership invitation&information
Stephen Clarke
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
jangeissler
 
Will global HCPs networks become communities of choice for rare-disease speci...
Will global HCPs networks become communities of choice for rare-disease speci...Will global HCPs networks become communities of choice for rare-disease speci...
Will global HCPs networks become communities of choice for rare-disease speci...
Len Starnes
 
The critical crossroads of animal, human, and environmental health: Scaling u...
The critical crossroads of animal, human, and environmental health: Scaling u...The critical crossroads of animal, human, and environmental health: Scaling u...
The critical crossroads of animal, human, and environmental health: Scaling u...
ILRI
 
Digital African health library by Bruce Dahlman, INFAMED
Digital African health library by Bruce Dahlman, INFAMEDDigital African health library by Bruce Dahlman, INFAMED
Digital African health library by Bruce Dahlman, INFAMEDachapkenya
 
Communication & social media
Communication & social media Communication & social media
Communication & social media
EUPATI
 
European Patients Academy - Presentation of Jan Geissler at EPF AGM
European Patients Academy - Presentation of  Jan Geissler at EPF AGMEuropean Patients Academy - Presentation of  Jan Geissler at EPF AGM
European Patients Academy - Presentation of Jan Geissler at EPF AGM
jangeissler
 
Rehabilitation 2030 A call to action
Rehabilitation 2030 A call to actionRehabilitation 2030 A call to action
Rehabilitation 2030 A call to action
Emma Stokes
 
2010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.52010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.5jangeissler
 
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDISDay 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Canadian Organization for Rare Disorders
 
Denis Costello - Cambridge Rare Disease Summit 2015
Denis Costello - Cambridge Rare Disease Summit 2015Denis Costello - Cambridge Rare Disease Summit 2015
Denis Costello - Cambridge Rare Disease Summit 2015
CamRARE Disease Network
 
EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...
Nowgen
 
Boston Children's Hospital: Taming the Wild West, presented by Lily Vautour
Boston Children's Hospital: Taming the Wild West, presented by Lily VautourBoston Children's Hospital: Taming the Wild West, presented by Lily Vautour
Boston Children's Hospital: Taming the Wild West, presented by Lily Vautour
SocialMedia.org Health
 
The emergence of the e-patient
The emergence of the e-patientThe emergence of the e-patient
The emergence of the e-patient
jangeissler
 

Similar to Update on the Mysasthenia Gravis community on RareConnect.org (20)

Christel Nourissier Rare Disease Communities Intro
Christel Nourissier Rare Disease Communities IntroChristel Nourissier Rare Disease Communities Intro
Christel Nourissier Rare Disease Communities Intro
 
Patient entrepeneurs, pop up uni, 9am, 3 september 2015
Patient entrepeneurs, pop up uni, 9am, 3 september 2015Patient entrepeneurs, pop up uni, 9am, 3 september 2015
Patient entrepeneurs, pop up uni, 9am, 3 september 2015
 
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
 
The Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacyThe Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacy
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare disease
 
Clinical Social Franchising: Organizing private healthcare providers to addre...
Clinical Social Franchising: Organizing private healthcare providers to addre...Clinical Social Franchising: Organizing private healthcare providers to addre...
Clinical Social Franchising: Organizing private healthcare providers to addre...
 
Iadpo membership invitation&information
Iadpo membership invitation&informationIadpo membership invitation&information
Iadpo membership invitation&information
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 
Will global HCPs networks become communities of choice for rare-disease speci...
Will global HCPs networks become communities of choice for rare-disease speci...Will global HCPs networks become communities of choice for rare-disease speci...
Will global HCPs networks become communities of choice for rare-disease speci...
 
The critical crossroads of animal, human, and environmental health: Scaling u...
The critical crossroads of animal, human, and environmental health: Scaling u...The critical crossroads of animal, human, and environmental health: Scaling u...
The critical crossroads of animal, human, and environmental health: Scaling u...
 
Digital African health library by Bruce Dahlman, INFAMED
Digital African health library by Bruce Dahlman, INFAMEDDigital African health library by Bruce Dahlman, INFAMED
Digital African health library by Bruce Dahlman, INFAMED
 
Communication & social media
Communication & social media Communication & social media
Communication & social media
 
European Patients Academy - Presentation of Jan Geissler at EPF AGM
European Patients Academy - Presentation of  Jan Geissler at EPF AGMEuropean Patients Academy - Presentation of  Jan Geissler at EPF AGM
European Patients Academy - Presentation of Jan Geissler at EPF AGM
 
Rehabilitation 2030 A call to action
Rehabilitation 2030 A call to actionRehabilitation 2030 A call to action
Rehabilitation 2030 A call to action
 
2010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.52010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.5
 
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDISDay 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
 
Denis Costello - Cambridge Rare Disease Summit 2015
Denis Costello - Cambridge Rare Disease Summit 2015Denis Costello - Cambridge Rare Disease Summit 2015
Denis Costello - Cambridge Rare Disease Summit 2015
 
EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...
 
Boston Children's Hospital: Taming the Wild West, presented by Lily Vautour
Boston Children's Hospital: Taming the Wild West, presented by Lily VautourBoston Children's Hospital: Taming the Wild West, presented by Lily Vautour
Boston Children's Hospital: Taming the Wild West, presented by Lily Vautour
 
The emergence of the e-patient
The emergence of the e-patientThe emergence of the e-patient
The emergence of the e-patient
 

More from EURORDIS - Rare Diseases Europe

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...
EURORDIS - Rare Diseases Europe
 
Living with TRAPS poll results
Living with TRAPS poll resultsLiving with TRAPS poll results
Living with TRAPS poll results
EURORDIS - Rare Diseases Europe
 
Pitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.orgPitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.org
EURORDIS - Rare Diseases Europe
 
The Value of Online Communities
The Value of Online CommunitiesThe Value of Online Communities
The Value of Online Communities
EURORDIS - Rare Diseases Europe
 
Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014
EURORDIS - Rare Diseases Europe
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyEURORDIS - Rare Diseases Europe
 
Rare disease day 2011 highlights
Rare disease day 2011 highlightsRare disease day 2011 highlights
Rare disease day 2011 highlights
EURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
EURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
EURORDIS - Rare Diseases Europe
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...EURORDIS - Rare Diseases Europe
 
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
EURORDIS - Rare Diseases Europe
 
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe" Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
EURORDIS - Rare Diseases Europe
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
EURORDIS - Rare Diseases Europe
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...
EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Presentation of the Epi-Rare project"
Workshop 3 - "Presentation of the Epi-Rare project"Workshop 3 - "Presentation of the Epi-Rare project"
Workshop 3 - "Presentation of the Epi-Rare project"
EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"
EURORDIS - Rare Diseases Europe
 
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
EURORDIS - Rare Diseases Europe
 
Conference 4 - The patient experience in the development and implementation ...
Conference 4 - The patient experience  in the development and implementation ...Conference 4 - The patient experience  in the development and implementation ...
Conference 4 - The patient experience in the development and implementation ...
EURORDIS - Rare Diseases Europe
 

More from EURORDIS - Rare Diseases Europe (20)

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...
 
Living with TRAPS poll results
Living with TRAPS poll resultsLiving with TRAPS poll results
Living with TRAPS poll results
 
Pitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.orgPitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.org
 
The Value of Online Communities
The Value of Online CommunitiesThe Value of Online Communities
The Value of Online Communities
 
Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014
 
Surveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org ExperienceSurveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org Experience
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients Globally
 
Rare disease day 2011 highlights
Rare disease day 2011 highlightsRare disease day 2011 highlights
Rare disease day 2011 highlights
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...
 
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
 
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe" Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...
 
Workshop 3 - "Presentation of the Epi-Rare project"
Workshop 3 - "Presentation of the Epi-Rare project"Workshop 3 - "Presentation of the Epi-Rare project"
Workshop 3 - "Presentation of the Epi-Rare project"
 
Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"
 
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
 
Conference 4 - The patient experience in the development and implementation ...
Conference 4 - The patient experience  in the development and implementation ...Conference 4 - The patient experience  in the development and implementation ...
Conference 4 - The patient experience in the development and implementation ...
 

Recently uploaded

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 

Recently uploaded (20)

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 

Update on the Mysasthenia Gravis community on RareConnect.org

  • 1. Rob Pleticha, Online Communities Manager, EURORDIS International MG Community
  • 2. EURORDIS is a non-governmental patient- driven alliance of patient organisations representing 571 rare disease patient organisations in 52 countries.
  • 3. RareConnect project RareConnect.org is an online social network for patients and families. Communities are built in partnership with patient groups who help create, moderate, and maintain. Each community is in 5 languages with human translation. There are 54 rare diseases currently listed on RareConnect, including porphyria.
  • 4. MG community on RareConnect Patient-centered community that promotes global conversation and connections between patients, families and caregivers to improve the lives of people living with rare diseases.
  • 5. Project Aims • facilitate patient and carer peer support • empower patients and carers to trust their experience • promote progress in research through patient generated knowledge • build relationships by inviting intervention from medical professionals
  • 6. MG Community • Launched June 2013 in 5 languages – FR, EN, DE, IT, ES • Seeded with stories, videos, articles… • Human translation of all future stories automatically • On demand human translation and Google Translator for forum posts
  • 7. MG Community • Many topics set for discussion, few responses. • 145 registered members who have written 7 testimonials. • 3 articles and 31 forum topics. Let’s go over some statistics from the MG community…
  • 8. Partners and Patient groups involved
  • 9. The MG community in numbers 5,608 total unique visitors (since June 19th)
  • 10. Where do the members come from? 1. Unknown 38 2. Italy 27 3. United States 16 4. United Kingsom 9 5. Spain 9 6. Romania 8 7. France 9 8. Ireland 3 9. Martinique 2 10. Switzerland 2 11. Perú 2 12. Hungary 1 13. Netherlands 1 Total of Members: 145
  • 11. Where do visitors come from? 1. Italy 1,112 2. United States 916 3. France 692 4. Germany 325 5. Spain 316 6. United Kingdom 316 7. Mexico 297 9. Romania 202 10. Canada 126 11. Belgium 118 12. Hungary 106 13. Peru 81 Total of countries: 89 Total of visitors: 5,608
  • 12. How do visitors find the community? –Google  3,046 –Direct traffic  812 –Facebook  806 –Mobile Facebook  375 –Eurordis.org 118 –Miastenie.ro 90 –Twitter 73
  • 13. Which search terms are used? – myasthenia gravis – miastenia gravis – myasthenia gravis association – myasthénie forum – myasthenie medicaments interdits – miastenia – alimentazione miastenia gravis – liste medicaments interdit myasthenie – miastenia gravis forum – myasthenia gravis uk - myasthenia gravis video - myasthénie grave - sport e miastenia - www.mga-charity.org - accociation de myasthénie grav
  • 14. Which topics are being discussed?
  • 15. Why the MG community on RareConnect? • Patient data is not sold • Patient groups govern the community and drive where the project goes • Human translation of stories and forum posts across 5 languages on key issues like accessing treatments • Help us create an international space for supporting patients and their families
  • 16. Privacy on RareConnect • You can decide if you want a public or private profile. • Check a box and your message will only be viewable for registered members. • Use a nickname. • The RareConnect team keeps an eye on all the community members to ensure they belong there.
  • 17. If a patient group wants to be involved on the MG Community • Join: http://www.rareconnect.org/en/register • Encourage your members to join the international conversation enabled by human translation • Share the link to the Community on your website, social media, newsletter • Place badge on your website/blog or add RSS feed to your website • Post updates on your group’s activities, share an update to your family’s journey
  • 18. How can we grow and engage members? What new content can be added?
  • 19. Keeping communities active • Organise a webinar with a specialist or researcher • Ask a healthcare professional to write about their work • Create a short video interview • Share photos from your recent event • Share your story as a patient or a caregiver
  • 20. Trimethylaminuria (TMAU) Webinars • 5 webinars with prominent specialists • Over 140 attendees • Webinars are recorded • Researchers answer patient questions after the presentation • Patients use webinar as gathering place to share experience via chat
  • 21.
  • 24. Community poll & Infographic - Translated into 5 languages - Designed by patient groups
  • 25. Community poll & Infographic - Visual and attractive - Perfect for Social Media - Available in 6 languages (including chinese)
  • 29. RareConnect vs. Facebook Here are a few differences between RareConnect and Facebook: - Facebook has advertising and sells your information to marketers. - RareConnect does not have advertising and does not share information with ANY 3rd parties. - RareConnect has human translation across 5 languages. - Facebook uses machine translation. -Facebook may delete old posts in Groups, without warning or explanation, old messages disappear. - RareConnect keeps all messages and stories in the same place, with permanent links. - Facebook isn't that concerned with rare diseases. - RareConnect staff at EURORDIS and NORD want to assist patient groups in using RareConnect to build an international diseases movement.
  • 30. www.facebook.com/rareconnect robert.pleticha@eurordis.org marta.campabadal@eurordis.org +34 663 092 790 @rareconnect www.youtube.com/user/eurordis Thanks, let us know how we can work together More information: